Impact of an Infusion Therapy Nursing Expert Service on Length of Stay and Clinical Results of Venous Access Devices

Basque Health Service82 enrolled

Overview

The purpose of this study is to determine whether an infusion therapy nursing expert service is effective in decreasing hospital length of stay, improving the clinical results of venous access devices and increasing patient satisfaction with venous access.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

HEALTH_SERVICES_RESEARCH

Masking

SINGLE

Enrollment

Conditions

Patients With Prolonged Intravenous Therapy

Interventions

Infusion therapy nursing expert serviceOTHER

The ITNE will assess the patient and treatment characteristics and use an evidence based decision making algorithm for the selection of the most suitable VAD. If the VAD needed is a PICC or a midline ITNE will place it following hospital's protocols. If needed, ITNE will also educate and support patients and next of keens in the maintenance of the device at home. If other devices such as peripheral catheters, central venous catheters (jugular or subclavian) or venous subcutaneous reservoirs are the preferable VADs for patients and treatment conditions, ITNE will work together with health professionals in charge of patients to activate the usual procedures to place the according device.

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Require an estimated long prescription of intravenous treatment. These treatments may be of fluid therapy, pharmacological, nutritional or hemotherapy. * Estimation of 7 days or more of continuous intravenous therapy. * Estimation of an intermittent intravenous therapy of less than a week, but on a monthly basis or less and a total estimated duration superior to 3 months. * Be patient at Araba University Hospital Exclusion Criteria: * To have a central venous catheter indwelled * MRSA (Methicillin Resistant Staphylococcus Aureus) * Younger than 18 years old

Locations (1)

Araba University Hospital

Vitoria-Gasteiz, Araba, Spain

Outcomes

Primary Outcomes

Hospital Length of Stay

Time frame: 3 months

Secondary Outcomes

Venous Access Devices reaching end of treatment

Time frame: 3 months

Incidence of complications derived from VAD

Time frame: 3 months

Patients receiving intravenous therapy at home

Time frame: 3 months

Patient satisfaction with VAD

Time frame: 3 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.